PHS
AGN

PFM Health Sciences’s Allergan Inc AGN Stock Holding History

PFM Health Sciences’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-501,268
Closed -$107M – 113
2014
Q4 		$107M Sell
501,268
-261,085
-34% -$51.9M 2.49% 10
2014
Q3 		$136M Sell
762,353
-866,517
-53% -$144M 3.13% 12
2014
Q2 		$276M Buy
1,628,870
+888,487
+120% +$138M 5.51% 1
2014
Q1 		$91.9M Buy
740,383
+289,433
+64% +$35.2M 1.67% 20
2013
Q4 		$50.1M Buy
+450,950
New +$43.1M 1.01% 33

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

PFM Health Sciences's AGN Position: Q1 2015 in Review

PFM Health Sciences sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 501,268 shares — an estimated $107M sold.

PFM Health Sciences first reported a position in AGN in Q4 2013 and held it in 5 quarters. The position peaked at $276M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • PFM Health Sciences reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • PFM Health Sciences sold 501,268 Allergan Inc shares in Q1 2015, an estimated $107M.
  • PFM Health Sciences first reported a position in Allergan Inc in Q4 2013 and held it in 5 quarters.
  • PFM Health Sciences's Allergan Inc position peaked at $276M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on PFM Health Sciences's 13F filing for Q1 2015, filed 15 May 2015.